Clear Cell Renal Cell Carcinoma (ccRCC)

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Philogen
PhilogenItaly - Monteriggioni
1 program
1
[68Ga]Ga-OncoCAIXPhase 11 trial
Active Trials
NCT06840548Completed20Est. Nov 2025

Trial Timeline

Clinical trial activity over time

2025
2026
Philogen[68Ga]Ga-OncoCAIX

Clinical Trials (1)

Total enrollment: 20 patients across 1 trials

NCT06840548Philogen[68Ga]Ga-OncoCAIX

A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer

Start: Apr 2025Est. completion: Nov 202520 patients
Phase 1Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space